FDA expects many products to disappear with new regime


Looking ahead • Costs and grandfathering • Products, stores and suppliers • What this means


The number of products on the U.S. e-cigarette market will contract sharply after the new deeming regulations come into full effect, according to their architect the Food and Drug Administration (FDA) – and its predictions suggest a sudden slowdown in innovation too.


The FDA, which released the final version of the regulations two weeks ago but will not be fully enforcing them for about two years, predicts that although 90% of applications for the necessary approvals will succeed, the vast majority of products will be withdrawn from the market by their makers without being submitted for the application process.

ECigIntelligence does not provide legal, strategic or investment advice. Tamarind Media Limited, the publisher of ECigIntelligence, does not accept any liability or responsibility for information or views published.
Please see this page for a detailed description of our methodology.